Institute for Human Genetics Genotech Symposium

IHG Genotech Symposium September 22, 2025 Agenda

	Time	Who	Title	Talk Title
Introductions	9:00-9:05	Talmadge E. King Jr., MD	Dean, School of Medicine, UCSF Vice Chancellor, Medical Affairs, UCSF Health
	9:05-9:15	Nadav Ahituv, PhD	Director, Institute for Human Genetics, UCSF
Gene Therapy	9:15-9:35	Jacob Kimmel, PhD	Co-founder & President, NewLimit	Restoring youthful function with reprogramming therapies
	9:35-9:55	Dan Hart, PhD	Head of Platform, Epicrispr Biotechnologies	EPIC GEMS: An Epigenetic Editing Platform for In vivo Therapeutic Applications
	9:55-10:15	Paul Donohoue	Director of Platform Discovery, Caribou Biosciences	A versatile CRISPR hybrid RNA-DNA editing technology for the generation of off-the-shelf cell therapies
	10:15-10:35	Chris Hsiung, MD, PhD	Assistant Professor, Institute for Human Genetics and Dept. of Surgery, UCSF	Higher-order combinatorial functional genomics
	10:35-11:05	Panel Discussion
Break	11:05-11:35
Keynote Speaker	11:35-12:20	Michael Snyder, PhD	Stanford W. Ascherman Professor of Genetics, Stanford University	The Genetic Basis of Complex Diseases Revealed Using AI methods
Lunch & Career Panel	12:20-1:35	KT Moortgat, PhD Shishi Luo, PhD Mike Schnall-Levin, PhD Michael Snyder, PhD	Founder, Managing Partner, Dalena Capital Director of Bioinformatics, Helix Chief Technology Officer, Founding Scientist, 10X Genomics Stanford W. Ascherman Professor of Genetics, Stanford University	The career panel will be a round table discussion. Nick Page, Neuroscience PhD, will lead the discussion with a few questions to get the ball rolling and from there we can take questions from trainees in the audience. Come learn more about exciting and impactful career paths in the biotech industry. To join, register here and take your lunch to room GH-N114 on the first floor of the Genentech building.
AI	1:35-1:55	Kyle Farh, MD, PhD	VP & Distinguished Scientist, Illumina Artificial Intelligence Lab
	1:55-2:15	Shishi Luo, PhD	Director of Bioinformatics, Helix	Precision Medicine: From Exome Data to Drug Response with a Little Help from LLMs
	2:15-2:35	Xiao Yang, PhD	Co-founder & CEO, PromptBio	PromptBio: A Multi-Agent AI Platform for Bioinformatics Data Analysis
	2:35-2:55	Jeff Spence, PhD	Assistant Professor, Department of Epidemiology & Biostatistics, UCSF	Accurate estimation of gene constraint by combining interpretable models and machine learning
	2:55-3:25	Panel Discussion
Break	3:25-3:55
Genomic Technologies	3:55-4:15	Kathleen Barnes, PhD	SVP Population & Precision Health, Oxford Nanopore
	4:15-4:35	Mike Schnall-Levin, PhD	Chief Technology Officer, Founding Scientist, 10X Genomics	Driving the Next Level of Scale of Single Cell and Spatial
	4:35-4:55	Matthew Kellinger, PhD	Co-founder & VP of Biochemistry, Element Biosciences	Unleashing the Multiomic Capabilities of AVITI24 to Empower Discovery
	4:55-5:15	Diego Calderon, PhD	Assistant Professor, Department of Bioengineering and Therapeutic Sciences, UCSF	The continuum of gene regulation at single-cell resolution, from Drosophilia development to human complex traits
	5:15-5:45	Panel Discussion
Reception	5:45